
Trump Announces Major Deal to Lower Costs of Weight Loss Drugs
President Trump has announced a significant deal with pharmaceutical companies Eli Lilly and Novo Nordisk to lower the prices of popular weight loss drugs, Wegovy and Zepbound, to as low as $149 a month. This initiative aims to make these medications more accessible for Medicare and Medicaid recipients, addressing the rising obesity rates in America and potentially improving health outcomes for millions struggling with weight management.










